Exelixis Announces EMA Acceptance of Marketing Authorization...
Exelixis, Inc. today announced the European Medicines Agency has accepted for review the Marketing Authorization Application for COMETRIQ for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer .
Join the discussion below, or Read more at Freshnews.
#1 Nov 30, 2012
Looking for more information on Cometriq? Here's a pharmacist's description: http://www.rxwiki.com/cometriq
#2 Dec 13, 2012
We don't have the time to keep up with the current marketing trends. We are looking for a marketing firm grand rapids who is forward thinking. Any recommendations?
Add your comments below
|Www.CoryandTopanga.Com No Longer Exists, Consid... (Aug '07)||Tue||Amy||47|
|Ideas on successful trade show exhibitor displ... (Jun '11)||Jul 28||halfprice||2|
|Nickelodeon TV Star Jennette McCurdy Named Bran... (Mar '14)||Jul 26||diana||2|
|My Pet: Teen Star McCurdy Fronts Tamagotchi Cam... (Mar '14)||Jul 26||diana||2|
|DRDO launches 'Lukoskin' herbal care product fo... (Sep '11)||Jul 26||Ajay kumar||1,151|
|Are vitamins from USANA worth price? (Mar '08)||Jul 22||Feeling good||221|
|Acid reflux disease hits Americans hard (Oct '08)||Jul 20||HowToTreatHeartbu...||15|
Find what you want!
Search Marketing Forum Now
Copyright © 2015 Topix LLC